{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T19:38:41Z","timestamp":1648755521295},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.humimm.2015.10.002","type":"journal-article","created":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T06:42:00Z","timestamp":1444891320000},"page":"29-34","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Increased proportions of dendritic cells and recovery of IFN\u03b3 responses in HIV\/HCV co-infected patients receiving ART"],"prefix":"10.1016","volume":"77","author":[{"given":"Henny","family":"Saraswati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dino","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evy","family":"Yunihastuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rino","family":"Gani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2015.10.002_b0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/89726","article-title":"Dendritic cell lineage, plasticity and cross-regulation","volume":"2","author":"Liu","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2015.10.002_b0010","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1182\/blood-2002-10-3189","article-title":"Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1","volume":"101","author":"Donaghy","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2015.10.002_b0015","first-page":"261","article-title":"Different subsets of peripheral blood dendritic cells show distinct phenotypic and functional abnormalities in HIV-1 infection","volume":"19","author":"Almeida","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.humimm.2015.10.002_b0020","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10875-004-6250-5","article-title":"Dendritic cell numbers in the blood of HIV-1 infected patients before and after changes in antiretroviral therapy","volume":"24","author":"Finke","year":"2004","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.humimm.2015.10.002_b0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1086\/345957","article-title":"Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals","volume":"187","author":"Barron","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.humimm.2015.10.002_b0030","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood.V98.10.3016","article-title":"Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection","volume":"98","author":"Pacanowski","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2015.10.002_b0035","doi-asserted-by":"crossref","first-page":"6710","DOI":"10.1128\/JVI.75.14.6710-6713.2001","article-title":"Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus","volume":"75","author":"Patterson","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.humimm.2015.10.002_b0040","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/vim.2009.0112","article-title":"Irreversible loss of pDCs by apoptosis during early HIV infection may be a critical determinant of immune dysfunction","volume":"23","author":"Meera","year":"2010","journal-title":"Viral Immunol."},{"key":"10.1016\/j.humimm.2015.10.002_b0045","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1128\/JVI.78.10.5223-5232.2004","article-title":"Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells","volume":"78","author":"Fonteneau","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.humimm.2015.10.002_b0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1128\/JVI.01118-10","volume":"85","author":"Dillon","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.humimm.2015.10.002_b0055","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.4049\/jimmunol.168.9.4796","article-title":"Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals","volume":"168","author":"Chehimi","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.002_b0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/clim.2001.5111","article-title":"Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors","volume":"101","author":"Feldman","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.humimm.2015.10.002_b0065","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.4049\/jimmunol.179.4.2642","article-title":"Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in HIV-1-infected subjects undergoing antiretroviral treatment","volume":"179","author":"Chehimi","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.002_b0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/QAD.0b013e328012b85f","article-title":"Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells","volume":"21","author":"Azzoni","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.humimm.2015.10.002_b0075","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/01.aids.0000232231.34253.bd","article-title":"Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment","volume":"20","author":"Killian","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.humimm.2015.10.002_b0080","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/hep.20592","article-title":"Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection","volume":"41","author":"Ulsenheimer","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.humimm.2015.10.002_b0085","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1182\/blood.V97.10.3171","article-title":"Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection","volume":"97","author":"Auffermann-Gretzinger","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2015.10.002_b0090","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/gast.2001.21212","article-title":"Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection","volume":"120","author":"Bain","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humimm.2015.10.002_b0095","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2249.2007.03367.x","article-title":"Monocyte-derived dendritic cell function in chronic hepatitis C is impaired at physiological numbers of dendritic cells","volume":"148","author":"MacDonald","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2015.10.002_b0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clim.2006.12.001","article-title":"Differential dysfunction in dendritic cell subsets during chronic HCV infection","volume":"123","author":"Averill","year":"2007","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.humimm.2015.10.002_b0105","doi-asserted-by":"crossref","first-page":"19642","DOI":"10.7448\/IAS.17.4.19642","article-title":"Plasmacytoid Dendritic cells (pDCs) in HIV-infected and HIV\/HCV-co-infected patients receiving successful treatment","volume":"17","author":"Khokhlova","year":"2014","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.humimm.2015.10.002_b0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/QAI.0b013e3182752d20","article-title":"Transient liver injury associated with the early recovery of HCV-specific T-cell responses and HCV rebound in HIV-1\/HCV coinfected patients undergoing highly active antiretroviral therapy","volume":"62","author":"Kang","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.humimm.2015.10.002_b0115","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1136\/gut.2005.083758","article-title":"Diminished frequency of hepatitis C virus specific interferon gamma secreting CD4+ T cells in human immunodeficiency virus\/hepatitis C virus coinfected patients","volume":"55","author":"Harcourt","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.humimm.2015.10.002_b0120","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.4049\/jimmunol.172.8.4907","article-title":"Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection","volume":"172","author":"Anthony","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.002_b0125","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/CVI.00141-07","article-title":"Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection","volume":"14","author":"Fan","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.humimm.2015.10.002_b0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clim.2010.12.013","article-title":"Antibody and markers of T-cell activation illuminate the pathogenesis of HCV immune restoration disease in HIV\/HCV co-infected patients commencing ART","volume":"139","author":"Yunihastuti","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.humimm.2015.10.002_b0135","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiu118","article-title":"Periportal CD4+ cell infiltration increases in HIV\/HCV co-infected patients commencing ART, whilst CD8+ cells clear from the liver","author":"Gani","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.humimm.2015.10.002_b0140","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1468-1293.2004.00245.x","article-title":"Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy","volume":"5","author":"Keane","year":"2004","journal-title":"HIV Med."},{"key":"10.1016\/j.humimm.2015.10.002_b0145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1743-422X-9-76","article-title":"Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection","volume":"9","author":"Riviere","year":"2012","journal-title":"Virol J."},{"key":"10.1016\/j.humimm.2015.10.002_b0150","doi-asserted-by":"crossref","first-page":"11392","DOI":"10.1128\/JVI.75.23.11392-11400.2001","article-title":"Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells","volume":"75","author":"Wedemeyer","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.humimm.2015.10.002_b0155","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CVI.00050-12","article-title":"Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection","volume":"19","author":"Abdelwahab","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.humimm.2015.10.002_b0160","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/jmv.23293","article-title":"Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients","volume":"84","author":"Anggorowati","year":"2012","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.humimm.2015.10.002_b0165","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(00)03232-3","article-title":"Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study","volume":"356","author":"Greub","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2015.10.002_b0170","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2893.2010.01331.x","article-title":"Decreased IFNgamma production correlates with diminished production of cytokines by dendritic cells in patients infected with hepatitis C virus and receiving therapy","volume":"18","author":"Hammond","year":"2011","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.humimm.2015.10.002_b0175","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1086\/431523","article-title":"Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C","volume":"192","author":"Longman","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.humimm.2015.10.002_b0180","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1099\/vir.0.83517-0","article-title":"Altered chemotactic response of myeloid and plasmacytoid dendritic cells from patients with chronic hepatitis C: role of alpha interferon","volume":"89","author":"Cicinnati","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.humimm.2015.10.002_b0185","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.4049\/jimmunol.177.10.6758","article-title":"Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection","volume":"177","author":"Dolganiuc","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.002_b0190","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jmv.20283","article-title":"Hepatitis C virus core, NS3, NS5A, NS5B proteins induce apoptosis in mature dendritic cells","volume":"75","author":"Siavoshian","year":"2005","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.humimm.2015.10.002_b0195","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.humimm.2010.05.006","article-title":"Functional changes, increased apoptosis, and diminished nuclear factor-kappaB activity of myeloid dendritic cells during chronic hepatitis C infection","volume":"71","author":"Zhao","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2015.10.002_b0200","doi-asserted-by":"crossref","first-page":"e37966","DOI":"10.1371\/journal.pone.0037966","article-title":"Longitudinal changes of peripheral blood DC subsets and regulatory T cells in Chinese chronic HIV-1-infected patients during antiretroviral therapy","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2015.10.002_b0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10875-006-8401-3","article-title":"Variations in plasmacytoid dendritic cell (PDC) and myeloid dendritic cell (MDC) levels in HIV-infected subjects on and off antiretroviral therapy","volume":"26","author":"Schmidt","year":"2006","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.humimm.2015.10.002_b0210","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/aid.2012.0200","article-title":"Plasmacytoid dendritic cell number and responses to Toll-like receptor 7 and 9 agonists vary in HIV Type 1-infected individuals in relation to clinical state","volume":"29","author":"Kaushik","year":"2013","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.humimm.2015.10.002_b0215","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1128\/JVI.07114-11","article-title":"Plasmacytoid dendritic cells reduce HIV production in elite controllers","volume":"86","author":"Machmach","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.humimm.2015.10.002_b0220","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.clim.2011.02.015","article-title":"Robust interferon-alpha and IL-12 responses by dendritic cells are related to efficient CD4+ T-cell recovery in HIV patients on ART","volume":"139","author":"Tan","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.humimm.2015.10.002_b0225","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/QAD.0b013e3282f4de35","article-title":"Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection","volume":"22","author":"Lester","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.humimm.2015.10.002_b0230","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/QAD.0b013e32825eab8b","article-title":"Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy","volume":"21","author":"Lim","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.humimm.2015.10.002_b0235","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3851\/IMP2671","article-title":"Pretreatment predictive factors for hepatitis C therapy outcome: relevance of anti-E1E2 antibodies compared to IP-10 and IL28B genotypes","volume":"18","author":"Arnaud","year":"2013","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.humimm.2015.10.002_b0240","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2567.2007.02577.x","article-title":"Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell proliferation in patients with hepatitis C virus infection","volume":"121","author":"Della Bella","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2015.10.002_b0245","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.21714","article-title":"Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy","volume":"46","author":"Rosen","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.humimm.2015.10.002_b0250","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1136\/gut.2009.205971","article-title":"Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy","volume":"59","author":"Rohrbach","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.humimm.2015.10.002_b0255","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-3083.2003.01234.x","article-title":"Partial restoration of cytokine profile despite reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients during highly active antiretroviral treatment","volume":"57","author":"Alfonzo","year":"2003","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.002_b0260","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1468-1293.2008.00565.x","article-title":"Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis","volume":"9","author":"Tan","year":"2008","journal-title":"HIV Med."},{"key":"10.1016\/j.humimm.2015.10.002_b0265","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.4049\/jimmunol.175.3.1636","article-title":"TLR7\/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production","volume":"175","author":"Hart","year":"2005","journal-title":"J. Immunol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885915005054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885915005054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T13:26:47Z","timestamp":1560518807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885915005054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0198885915005054"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2015.10.002","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased proportions of dendritic cells and recovery of IFN\u03b3 responses in HIV\/HCV co-infected patients receiving ART","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2015.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2015 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}